Lichen Teng

1.3k total citations
63 papers, 1.0k citations indexed

About

Lichen Teng is a scholar working on Rheumatology, Immunology and Cancer Research. According to data from OpenAlex, Lichen Teng has authored 63 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Rheumatology, 24 papers in Immunology and 12 papers in Cancer Research. Recurrent topics in Lichen Teng's work include Spondyloarthritis Studies and Treatments (21 papers), Psoriasis: Treatment and Pathogenesis (18 papers) and Rheumatoid Arthritis Research and Therapies (17 papers). Lichen Teng is often cited by papers focused on Spondyloarthritis Studies and Treatments (21 papers), Psoriasis: Treatment and Pathogenesis (18 papers) and Rheumatoid Arthritis Research and Therapies (17 papers). Lichen Teng collaborates with scholars based in China, United States and Canada. Lichen Teng's co-authors include Yajuan Su, Changfu Li, Nikolay Delev, Christopher J Edwards, Jacob Aelion, Maria Paris, Jeffrey R. Curtis, Dianne Nguyen, Akgun Ince and Herbert S. B. Baraf and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Lichen Teng

58 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lichen Teng China 17 371 299 270 228 156 63 1.0k
M. Á. Aguirre Spain 25 1.1k 3.1× 626 2.1× 475 1.8× 420 1.8× 254 1.6× 52 1.8k
Jae‐Yong Kwak South Korea 21 137 0.4× 225 0.8× 233 0.9× 303 1.3× 125 0.8× 115 1.3k
Ugochukwu C. Nzeako United States 14 180 0.5× 116 0.4× 144 0.5× 93 0.4× 108 0.7× 19 1.1k
Tsukasa Takemura Japan 20 110 0.3× 203 0.7× 322 1.2× 124 0.5× 59 0.4× 55 1.1k
Mingguo Huang Japan 20 221 0.6× 288 1.0× 433 1.6× 96 0.4× 254 1.6× 51 1.1k
Hajnalka Andrikovics Hungary 21 141 0.4× 151 0.5× 463 1.7× 467 2.0× 86 0.6× 90 1.2k
Roberto Scorza Italy 15 84 0.2× 206 0.7× 204 0.8× 130 0.6× 361 2.3× 19 859
Vibe Skov Denmark 24 452 1.2× 212 0.7× 725 2.7× 754 3.3× 107 0.7× 107 1.8k
Yu‐Nien Sun United States 13 155 0.4× 92 0.3× 298 1.1× 80 0.4× 120 0.8× 30 702
Frédéric Vanhoutte Belgium 15 390 1.1× 219 0.7× 235 0.9× 186 0.8× 19 0.1× 35 983

Countries citing papers authored by Lichen Teng

Since Specialization
Citations

This map shows the geographic impact of Lichen Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lichen Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lichen Teng more than expected).

Fields of papers citing papers by Lichen Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lichen Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lichen Teng. The network helps show where Lichen Teng may publish in the future.

Co-authorship network of co-authors of Lichen Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Lichen Teng. A scholar is included among the top collaborators of Lichen Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lichen Teng. Lichen Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wang, Xingyuan, Dechao Li, Lichen Teng, et al.. (2024). Pazopanib stimulates senescence of renal carcinoma cells through targeting nuclear factor E2‐related factor 2 (Nrf2). Journal of Biochemical and Molecular Toxicology. 38(4). e23689–e23689. 2 indexed citations
4.
5.
Mease, Philip J., Dafna D. Gladman, Alexis Ogdie, et al.. (2020). Treatment‐to‐Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations. Arthritis Care & Research. 72(6). 814–821. 7 indexed citations
6.
Li, Dechao, Changfu Li, Yongsheng Chen, et al.. (2020). LncRNA HOTAIR induces sunitinib resistance in renal cancer by acting as a competing endogenous RNA to regulate autophagy of renal cells. Cancer Cell International. 20(1). 338–338. 44 indexed citations
7.
Teng, Lichen, Li Li, Yong‐Sheng Chen, et al.. (2019). Total pelvic exenteration and a new model of diversion for giant primitive neuroectodermal tumor of prostate: A case report and review of the literature. Asian journal of urology. 7(2). 181–185. 2 indexed citations
8.
Kavanaugh, Arthur, Dafna D. Gladman, Christopher J Edwards, et al.. (2019). Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1–3 pooled analysis. Arthritis Research & Therapy. 21(1). 118–118. 57 indexed citations
9.
Chen, Chen, Yuming Luo, Yajuan Su, & Lichen Teng. (2019). The vitamin D receptor (VDR) protects pancreatic beta cells against Forkhead box class O1 (FOXO1)-induced mitochondrial dysfunction and cell apoptosis. Biomedicine & Pharmacotherapy. 117. 109170–109170. 32 indexed citations
10.
Wang, Wentao, Changfu Li, Yongsheng Chen, et al.. (2018). Increased expression of GGN promotes tumorigenesis in bladder cancer and is correlated with poor prognosis. Gene. 652. 7–15. 3 indexed citations
11.
Liu, Zhu, Lichen Teng, Ling-juan Gao, et al.. (2018). The role of eukaryotic translation initiation factor 5A-1 (eIF5A-1) gene in HPV 16 E6 induces cell growth in human cervical squamous carcinoma cells. Biochemical and Biophysical Research Communications. 504(1). 6–12. 11 indexed citations
12.
Mease, Philip J., Elliot D. Rosenstein, Feng Huang, et al.. (2018). SAT0347 Baseline characteristics of patients with psoriatic arthritis initiated on apremilast in the corrona psoriatic arthritis/spondyloarthritis (PSA/SPA) registry. Annals of the Rheumatic Diseases. 77. 1039–1039. 1 indexed citations
13.
Mease, Philip J., Dafna D. Gladman, Arthur Kavanaugh, et al.. (2017). Characterization of Clinical Benefits in Subjects Classified As ACR20 Non-Responders at Week 104 of Apremilast Treatment: Subanalysis of 3 Long-Term, Phase III Trials. Queensland's institutional digital repository (The University of Queensland). 69. 864–865. 1 indexed citations
14.
Teng, Lichen, et al.. (2014). Anti-tumor effect of ribavirin in combination with interferon-α on renal cell carcinoma cell lines in vitro. Cancer Cell International. 14(1). 63–63. 17 indexed citations
15.
Su, Yajuan, Ling-juan Gao, Lichen Teng, et al.. (2013). Id1 enhances human ovarian cancer endothelial progenitor cell angiogenesis via PI3K/Akt and NF-κB/MMP-2 signaling pathways. Journal of Translational Medicine. 11(1). 132–132. 44 indexed citations
16.
Teng, Lichen, Mitsutoshi Nakada, Hemragul Sabit, et al.. (2013). Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival. Neuro-Oncology. 15(12). 1710–1720. 28 indexed citations
17.
Teng, Lichen, et al.. (2013). Long-Term Outcome of Simultaneous or Staged Urinary Diversion and Kidney Transplantation. Urologia Internationalis. 91(3). 310–314. 4 indexed citations
18.
Teng, Lichen, et al.. (2012). Absolute of CD4+CD25+FOXP3+ Regulatory T-Cell Count Rather Than Its Ratio in Peripheral Blood Is Related to Long-Term Survival of Renal Allografts. Transplantation Proceedings. 44(1). 284–286. 14 indexed citations
19.
Bzowej, Natalie, David R. Nelson, Norah A. Terrault, et al.. (2011). PHOENIX. Liver Transplantation. 17(5). 528–538. 78 indexed citations
20.
Teng, Lichen, Changxi Wang, & Lizhong Chen. (2009). Effect of CYP3A5 polymorphism on tacrolimus concentration during early period after kidney transplantation in recipients. 30(5). 261–263. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Á. Aguirre Breakdown of academic impact, for papers by Jae‐Yong Kwak Breakdown of academic impact, for papers by Ugochukwu C. Nzeako Breakdown of academic impact, for papers by Tsukasa Takemura Breakdown of academic impact, for papers by Mingguo Huang Breakdown of academic impact, for papers by Hajnalka Andrikovics Breakdown of academic impact, for papers by Roberto Scorza Breakdown of academic impact, for papers by Vibe Skov Breakdown of academic impact, for papers by Yu‐Nien Sun Breakdown of academic impact, for papers by Frédéric Vanhoutte
Rankless by CCL
2026